Clonal Architectures Predict Clinical Outcome in Gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity

Stomach adenocarcinoma (STAD) is a highly heterogeneous disease. Due to the lack of effective molecular markers and personalized treatment, the prognosis of gastric cancer patients is still very poor. The ABSOLUTE algorithm and cancer cell fraction were used to evaluate the clonal and subclonal stat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Chenxia, Wu, Cuiling, Wang, Niuniu, Lian, Changhong, Yang, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085378/
https://www.ncbi.nlm.nih.gov/pubmed/33900127
http://dx.doi.org/10.1177/0963689721989606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085378/
https://www.ncbi.nlm.nih.gov/pubmed/33900127
http://dx.doi.org/10.1177/0963689721989606

Ejemplares similares